Anhui Provincial Hospital

This study tests whether a drug called polyene phosphatidylcholine, given before and after surgery, can protect the liver in people with liver cancer. About 96 participants will receive either the drug combo or standard care. The goal is to see if it reduces liver injury after la…

This study tests a new treatment made from special stem cells (iMSC) for people with a serious complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The treatment aims to control the disease by calming the immune system. Abo…

This early study tests a gene therapy called LCAR02 in up to 18 people with B-cell lymphoma that has relapsed or not responded to standard treatments. The therapy uses a modified gene to target and attack cancer cells. The main goals are to check safety and see if the treatment s…

This phase 3 trial is testing whether changing the timing of stem cell infusion after a single umbilical cord blood transplant can lower the risk of severe acute graft-versus-host disease (aGVHD) in people with blood cancers. The study will enroll 134 participants who are in remi…

This study looks at how long kidney transplant patients should take a common antibiotic (TMP-SMX) to prevent a serious lung infection called PJP. About 450 participants will be randomly assigned to different treatment durations. The goal is to find the safest and most effective l…

This study tests whether infusions of cells from umbilical cord blood can help people with mild to moderate Alzheimer's disease. Thirty participants will receive either a low dose, high dose, or a placebo (salt water) through an IV once a week for four weeks, plus a fifth dose a …

This phase 2 trial is testing whether a drug called ivonescimab, given together with a short course of targeted radiation, can help people with advanced esophageal cancer that has worsened after first treatment. The study will enroll 37 adults and track how long they live without…

This early-phase trial is testing a new therapy called Meta10-TIL for people with advanced solid tumors that have not responded to at least one prior treatment. The therapy uses a patient's own tumor-fighting immune cells, which are modified in the lab to work better, and then gi…

This study is creating a large database of 2000 people whose cancer has spread to the liver. Researchers will collect information on patients' health, treatments, and outcomes to learn more about the disease and improve future care. No new treatments are being tested; the goal is…